Evidence map›Paper›PMID 38429305›Full record

ArticleNutrition & diabetes2024

Anti-diabetic effect of anthocyanin cyanidin-3-O-glucoside: data from insulin resistant hepatocyte and diabetic mouse.

Xiang Ye, Wen Chen, Xu-Fan Huang, Fu-Jie Yan, Shui-Guang Deng, Xiao-Dong Zheng, Peng-Fei Shan

Open access · goldAbstract read
In one paragraph

Article in Nutrition & diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Licochalcone D fromInternational journal of molecular sciences · 2024
    Article
  15. Review
  16. N-Frontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiang Ye *Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Zhejiang University School of Medicine, 310058, Hangzhou, China.
Wen Chen *College of Biosystems Engineering and Food Science, Zhejiang University, 310058, Hangzhou, China.
Xu-Fan HuangDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital of Zhejiang University School of Medicine, 310058, Hangzhou, China.
Fu-Jie YanCollege of Biosystems Engineering and Food Science, Zhejiang University, 310058, Hangzhou, China.
Shui-Guang DengAdvanced Computing and System Laboratory, College of Computer Science and Technology, Zhejiang University, 310058, Hangzhou, China.
Xiao-Dong ZhengCollege of Biosystems Engineering and Food Science, Zhejiang University, 310058, Hangzhou, China. xdzhengzju@163.com.
Peng-Fei ShanDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital of Zhejiang University School of Medicine, 310058, Hangzhou, China. pengfeishan@zju.edu.cn.
Zhejiang University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81870564Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LHDMD24H030001
6 · The paper itself

Abstract

backgroundAnthocyanins are a group of natural products widely found in plants. They have been found to alleviate the disorders of glucose metabolism in type 2 diabetes mellitus (T2DM), while the underlying mechanisms remain unclear.

methodsHepG2 and L02 cells were incubated with 0.2 mM PA and 30 mM glucose for 24 h to induce IR, and cells treated with 5 mM glucose were used as the control. C57BL/6 J male mice and db/db male mice were fed with a chow diet and gavaged with pure water or cyanidin-3-O-glucoside (C3G) solution (150 mg/kg/day) for 6 weeks.

resultsIn this study, the anthocyanin C3G, extracted from red bayberry, was found to alleviate disorders of glucose metabolism, which resulted in increased insulin sensitivity in hepatocytes, and achieved by enhancing the glucose consumption as well as glycogen synthesis in insulin resistance (IR) hepatpcytes. Subsequently, the expression of key proteins involved in IR was detected by western blotting analysis. Protein tyrosine phosphatase-1B (PTP1B), a negative regulator of insulin signaling, could reduce cellular sensitivity to insulin by inhibiting the phosphorylation of insulin receptor substrate-2 (IRS-2). Results of this study showed that C3G inhibited the increase in PTP1B after high glucose and palmitic acid treatment. And this inhibition was accompanied by increased phosphorylation of IRS proteins. Furthermore, the effect of C3G on improving IR in vivo was validated by using a diabetic db/db mouse model.

conclusionThese findings demonstrated that C3G could alleviate IR in vitro and in vivo to increase insulin sensitivity, which may offer a new insight for regulating glucose metabolism during T2DM by using the natural dietary bioactive components. C3G promotes the phosphorylation of IRS-2 proteins by suppressing the expression of PTP1B, and then enhances the sensitivity of hepatocyte to insulin.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceAnimalsAnthocyaninsGlucoseGlucosidesHepatocytesInsulinMiceMice, Inbred C57BLAnthocyaninscyanidinGlucoseGlucosidesInsulin

Identifiers

PMID38429305
PMCPMC10907696
OpenAlexW4392356861

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.